ŌURA unveils two new metabolic health featuresMeals and Glucose are two new metabolic health features aimed at empowering members with personalized insights and actionable guidance. Sequel Med Tech, Senseonics integrate technologies to create AID system with one-year CGMTwiist expands compatibility offerings to become the first AID system compatible with Senseonics' Eversense 365. Abbott unveils new Libre app Abbott said its new Libre app offers a more user-friendly interface that makes tracking glucose readings easier and streamlines care. What retailers should know about consumers taking GLP-1s for weight loss An Acosta Group study finds that 76% of those who discontinued GLP-1s are eating the same amount or less and many report retaining healthy habits. Which states are most interested in Ozempic? New York ranks #1 for Ozempic-related search interest, which is 34% higher than the national average. FDA clears Dexcom G7 15 Day CGM System Dexcom G7 15 Day is now cleared for adults with diabetes. Owen Mumford debuts UnifineOTC pen needles UnifineOTC is a new line of over-the-counter pen needles designed to help pharmacies better serve patients managing diabetes. Hy-Vee offers free A1C screenings The A1C test measures average blood sugar levels over the past two to three months, which can identify prediabetes or diabetes. Meitheal intros 2 generics Meitheal Pharmaceuticals has launched generic Prostin VR and generic Victoza. Biocon Biologics, Civica collaborate to expand insulin Aspart access Biocon Biologics will supply Insulin Aspart drug substance to Civica, who will use the drug substance to produce Insulin Aspart drug product. 1 2 3 4 5 Next Last
